FEED - ENvue Medical Inc.

Sponsored segment. FDA-cleared electromagnetic navigation system for feeding tube placement. Deployed in 38 hospitals (<1% of addressable market). Expanding into pediatric, neonatal, vascular access, and robotic automation. CEO Dr. Doran Besser, chairman David Johnson (sold Convatec for $4.1B). Risks include micro-cap volatility, not yet profitable, potential dilution. Host presents as informational, not a direct recommendation.

Presented as a sponsored segment. The company has FDA-cleared technology for feeding tube navigation, is deployed in 38 hospitals, has expansion opportunities in pediatric and vascular access markets, and experienced leadership. However, it's a micro-cap with liquidity risk, not yet profitable, and may need dilution. The presenter explicitly says to do your own due diligence and be aware of risks.